IBBQ:NSD-Invesco Nasdaq Biotechnology ETF (USD)

ETF | Others |

Last Closing

USD 19.45

Change

0.00 (0.00)%

Market Cap

USD 0.04B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-3.44 (-7.21%)

USD 50.95B
QQQM Invesco NASDAQ 100 ETF

+0.23 (+0.13%)

USD 39.48B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.11 (+0.24%)

USD 22.06B
ACWI iShares MSCI ACWI ETF

-1.03 (-0.97%)

USD 18.95B
CGABL The Carlyle Group Inc. 4.625% ..

-0.38 (-2.19%)

USD 16.14B
SNDK Sandisk Corp

+1.37 (+4.55%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 5.17B
TSLL Direxion Shares ETF Trust - Di..

-0.40 (-5.04%)

USD 3.11B
NVDL GraniteShares 1.5x Long NVDA D..

+1.94 (+7.01%)

USD 3.04B
ETHA iShares Ethereum Trust ETF

-2.07 (-15.11%)

USD 2.37B

ETFs Containing IBBQ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.62% 41% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.62% 41% F 59% D-
Trailing 12 Months  
Capital Gain -9.20% 35% F 53% F
Dividend Return 0.65% 23% F 14% F
Total Return -8.54% 33% F 52% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.53% 47% F 43% F
Dividend Return 0.88% 41% F 39% F
Total Return 0.36% 28% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 11.81% 48% F 86% B+
Risk Adjusted Return 7.49% 35% F 42% F
Market Capitalization 0.04B 54% F 27% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.